The inaugural honor from the American Society for Radiation Oncology (ASTRO) recognizes longstanding contributions to cancer care technology, education, and clinical research.
RT’s Three Key Takeaways:
- Inaugural Industry Honor: The American Society for Radiation Oncology named Siemens Healthineers the first recipient of its Corporate Partner Award to recognize sustained contributions to cancer treatment and patient care.
- Workforce and Research Support: The partnership between the medical society and Siemens Healthineers has funded clinical research fellowships for resident physicians and mentored research experiences for medical students.
- Technology Development Focus: Through Varian, the company continues to collaborate with multidisciplinary clinical teams to address practical healthcare delivery challenges and refine how therapies are planned and delivered.
The American Society for Radiation Oncology (ASTRO) named Siemens Healthineers the inaugural recipient of its Corporate Partner Award, according to the organization.
The award honors an organization whose collaboration, commitment, and generosity have influenced the field of radiation oncology and patient care worldwide. Presentation of the award took place during an awards ceremony at the 2026 ASTRO Annual Meeting in Boston, alongside recognition at the ASTRO Gold Medal Gala supporting research funding through Speed of Light – The ASTRO Foundation, according to the organization.
“Collaboration across the radiation oncology community is essential to moving our field forward and improving care for patients,” said Vivek S Kavadi, MD, MBA, FASTRO, chief executive officer of ASTRO. “For decades, Siemens Healthineers and Varian have worked alongside radiation oncology professionals as the science and technology of cancer treatment have evolved. Their longstanding partnership with ASTRO reflects a shared commitment to continued innovation and to expanding what is possible for people with cancer.”
Advancing Research and Clinical Pipelines
Operating through Varian, Siemens Healthineers stands as one of ASTRO’s longest-standing corporate members, according to the announcement. The company has contributed to technical advancements that have guided modern radiation therapy delivery, planning systems, and ongoing oncology workflows across acute healthcare environments.
Beyond equipment and software development, the collaboration has supported healthcare workforce initiatives and oncology research, the organization reported. Initiatives include backing industry-based clinical research fellowships for resident physicians and supporting ASTRO’s Medical Student Fellowship Awards, which provide medical students with mentored research opportunities in radiation medicine.
“We are honored to receive ASTRO’s inaugural Corporate Partner Award,” said Arthur Kaindl, head of Varian, the Siemens Healthineers cancer-care business. “Our work with ASTRO keeps us closely connected to the challenges facing radiation oncology and to the people delivering care every day. That perspective is essential as we work to develop technologies that can make a meaningful difference for patients.”
ASTRO established the award in 2026 to emphasize the importance of industry and clinical collaboration in meeting the shifting demands of oncology care, multidisciplinary clinical teams, and patient populations worldwide.
